Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

In trial

Labelling die variables as T, S and M, widi reference symbols, a, b, c respectively in trials involving a low (1) and high (h) levels of each variable, each trial having die result jc, die factorial procedure would produce die design code as follows ... [Pg.365]

Let us examine some batch results. In trials in which 5 mL of a dye solution was added by pipet (with pressure) to 10 mL of water in a 25-mL flask, which was shaken to mix (as determined visually), and the mixed solution was delivered into a 3-mL rectangular cuvette, it was found that = 3-5 s, 2-4 s, and /obs 3-5 s. This is characteristic of conventional batch operation. Simple modifications can reduce this dead time. Reaction vessels designed for photometric titrations - may be useful kinetic tools. For reactions that are followed spectrophotometrically this technique is valuable Make a flat button on the end of a 4-in. length of glass rod. Deliver 3 mL of reaction medium into the rectangular cuvette in the spectrophotometer cell compartment. Transfer 10-100 p.L of a reactant stock solution to the button on the rod. Lower this into the cuvette, mix the solution with a few rapid vertical movements of the rod, and begin recording the dead time will be 3-8 s. A commercial version of the stirrer is available. [Pg.177]

To properly describe electronic rearrangement and its dependence on both nuclear positions and velocities, it is necessary to develop a time-dependent theory of the electronic dynamics in molecular systems. A very useful approximation in this regard is the time-dependent Hartree-Fock approximation (34). Its combination with the eikonal treatment has been called the Eik/TDHF approximation, and has been implemented for ion-atom collisions.(21, 35-37) Approximations can be systematically developed from time-dependent variational principles.(38-41) These can be stated for wavefunctions and lead to differential equations for time-dependent parameters present in trial wavefunctions. [Pg.319]

Working with an established Tier 1 supplier Houghton International, Ford selected a two-phase metalworking lubricant/coolant based on vegetable oil. In trials at the Dagenham Engine Plant Ford foimd many benefits ... [Pg.66]

Pesticides used on crops grown on the test site in previous seasons may also have an impact on the outcome of a field residue trial. Carryover of prior pesticide applications could contaminate samples in a new trial, complicate the growth of the crop in a trial, or cause interference with procedures in the analytical laboratory. For this reason, an accurate history of what has transpired at the potential test site must be obtained before the trial is actually installed. The protocol should identify any chemicals of concern. If questions arise when the history is obtained, they should be reviewed with the Study Director prior to proceeding with the test site. In most annual crop trials, this will not be a significant issue owing to crop rotations in the normal production practices, because the use of short residual pesticides and different chemical classes is often required for each respective crop in the rotation. However, in many perennial crops (tree, vines, alfalfa, etc.) and monoculture row crops (cotton, sugarcane, etc.), the crop pesticide history will play a significant role in trial site selection. [Pg.151]

Many patients cannot tolerate chronic ACE inhibitor therapy secondary to adverse effects outlined below. Alternatively, the angiotensin receptor blockers (ARBs), can-desartan and valsartan, have been documented in trials to improve clinical outcomes in patients with heart failure.68,69 Therefore, either an ACE inhibitor or candesartan or valsartan are acceptable choices for chronic therapy for patients who have a low ejection fraction (EF) and heart failure following MI. Since more than five different ACE inhibitors have proven benefits in MI while only two ARBs have been studied, the benefits of ACE inhibitors are generally considered a... [Pg.102]

Raloxifene increases bone mineral density and reduces fracture rates. In trials of 1 to 3 years, raloxifene increased vertebral and hip bone mineral density by 2% to 3% and 1% to 2%, respectively.30 32 In the Multiple Outcomes for Raloxifene Evaluation (MORE) trial, raloxifene decreased the risk of vertebral fractures by 30% in postmenopausal with at least one prior fracture.30 No significant reduction in nonvertebral fractures was reported. [Pg.862]

If mast cell stabilizers or multiple-action agents are not successful, a trial of a topical NSAID is appropriate. Ketorolac is the only approved topical agent for ocular itching. NSAIDs do not mask ocular infections, affect wound healing, increase intraocular pressure, or contribute to cataract formation like the topical corticosteroids. However, for allergic conjunctivitis, topical ketorolac is not as effective as olopatadine or emedas-tine in trials.15 Full efficacy of ketorolac takes up to 2 weeks.17... [Pg.941]

In trials with wood since 1910, several researchers did notice pyrolytic heat release, but others found the reaction endothermic. The contradictions can be explained with different sizes of the samples. It is believed that primary pyrolysis volatiles interact in secondary, exothermic reactions catalyzed by the solid residue. Long residence times of the volatiles in the disintegrating material favor secondary reactions, of course. Residence times are indeed long in large and in slowly disintegrating samples, in which the volatiles have a long path to the surface and migrate out slowly. [Pg.434]

Figure 2 gives rates of pyrolysis in trials with gradually increasing temperatures. In the case of wood heated to 500 C for example, the volatile increments increase from temperature step to temperature step up to 300 C, dropping off in further steps. The sum of the increments reaches 75% at 500 C, as they should according to Figure 1. The area under the curve corresponds to that sum. One can estimate the sum for each final temperature from the areas. For example, in the case of heating to 250 C, the increments average 0.1%, and the sum of the increments becomes 0.1 x (250 - 100) = 0.1 x 150 = 15%, or 0.15 g/g (compare Figure 1). Figure 2 gives rates of pyrolysis in trials with gradually increasing temperatures. In the case of wood heated to 500 C for example, the volatile increments increase from temperature step to temperature step up to 300 C, dropping off in further steps. The sum of the increments reaches 75% at 500 C, as they should according to Figure 1. The area under the curve corresponds to that sum. One can estimate the sum for each final temperature from the areas. For example, in the case of heating to 250 C, the increments average 0.1%, and the sum of the increments becomes 0.1 x (250 - 100) = 0.1 x 150 = 15%, or 0.15 g/g (compare Figure 1).
Table I. Heat (H) of pyrolysis per gram volatiles in trials with wood by various authors... Table I. Heat (H) of pyrolysis per gram volatiles in trials with wood by various authors...
Nortriptyline is initiated 10 to 28 days before the quit date. The dose is initiated at 25 mg/day, gradually increasing to 75 to 100 mg/day. Treatment duration is commonly 12 weeks in trials, and common side effects were sedation, dry mouth, blurred vision, urinary retention, and lightheadedness. [Pg.851]

Positive Slope The mL and mole ratio for equivalency is 4 NaClO to 1 Na2S203 (see 1 above). In examining the data table, it can be seen that the Na2S203 is in excess, with the NaClO being the limiting reactant for example, in Trial 7, for 30 mL of 0.500 M NaClO,... [Pg.280]


See other pages where In trial is mentioned: [Pg.173]    [Pg.23]    [Pg.470]    [Pg.462]    [Pg.177]    [Pg.845]    [Pg.1190]    [Pg.71]    [Pg.82]    [Pg.329]    [Pg.244]    [Pg.312]    [Pg.545]    [Pg.545]    [Pg.760]    [Pg.142]    [Pg.8]    [Pg.971]    [Pg.67]    [Pg.64]    [Pg.66]    [Pg.333]    [Pg.101]    [Pg.151]    [Pg.379]    [Pg.786]    [Pg.161]    [Pg.192]    [Pg.291]    [Pg.304]    [Pg.154]    [Pg.281]    [Pg.138]   
See also in sourсe #XX -- [ Pg.443 ]




SEARCH



A common design in therapeutic exploratory and confirmatory trials

ADR Detection in Clinical Trials

AIDS vaccines in clinical trials

Additional statistical considerations in clinical trials

Allocating Treatments to Patients in Clinical Trials

Allocolchicinoids in clinical trials

Authorisation of Clinical Trials in the US

Central Principles of Experimental Design in Clinical Trials

Clinical Trials in The US

Clinical Trials in the EU

Clinical trials in children

Compliance in clinical trials

Concluding comments on safety assessments in clinical trials

Control group in clinical trials

Control in clinical trials

Deaths in clinical trials

Defibrillation in acute myocardial infarction trial

Defibrillator in acute myocardial infarction trial

Eli Lilly Hides Increased Suicidality on Prozac in Controlled Clinical Trials

Endpoints and markers in clinical trials

Ethics in clinical trials

First-in-human clinical trials

First-in-human trials

Fraud in clinical trials

Gas spike surveys and wells in trial pits

In vivo preclinical model trial

In-situ trial

Interim Analyses in Group Sequential Trials

Methodology to minimize bias in open-label trials

No Completed Suicides in the Clinical Trials

Non-protein inhibitors in clinical trials

Other issues in making trials effective

Pharmacoeconomics in clinical trials

Primary angioplasty in myocardial infarction trial

Study Design in Drug Clinical Trials

Sudden cardiac death in heart failure trial

Surrogate End Points in Clinical Trials of ACE Inhibition Are We Being Misled

Target Identification and Validation Clinical Trial in a Dish

The rationale for safety assessments in clinical trials

The relationship between hypothesis testing and ethics in clinical trials

The role of clinical trials in new drug development

Thrombolysis in Myocardial Infarction trial

Valiolamines in clinical trials

Valsartan in acute myocardial infarction trial

Valsartan in acute myocardial infarction trial VALIANT)

© 2024 chempedia.info